BioSpace News Archive

Infinant Health, Inc, a company focused on improving infant health through the gut microbiome, today announced the enrollment of the final participant in a study focused on the infant microbiome and immune health.

SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease (AD), is pleased to announce the publication of “Clinical Utility of a Novel Test to Diagnose Alzheimer’s Disease in Patients with Suspected Dementia” in Annals of Clinical Cytology and Pathology.

Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, today announced that C3 Souvenir Holding Inc. (“C3"), an established cannabis cultivator in Quebec, Canada, has completed the acquisition of Verdélite Sciences, Inc

Psycheceutical Bioscience, Inc. (OTCPK: BWVI) (“Psycheceutical” or the “Company”) today announced it has entered into an exclusive agreement with iNGENū Pty Ltd. (“iNGENū”), an Australian-based Contract Research Organization (CRO), to design and conduct two clinical trials to evaluate Psycheceutical’s patented NeuroDirect™ ketamine topical delivery system.

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that the Company’s recent submission of Fexapotide Triflutate for the treatment of symptoms of benign prostate enlargement (benign prostatic hyperplasia, referred to as BPH) has been validated by the Denmark authorities, and the formal review process has now started.

ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the year ended December 31, 2022 after the market closes on Tuesday, February 21, 2023.

BD, a leading global medical technology company, announced that the company has been named to America’s Best Large Employers List 2023 by Forbes, furthering its progress against the company’s environmental, social and governance strategy.

POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL) today announced its cash position and revenue and provided a corporate update for the twelve months ended December 31, 2022.

Cytokinetics, Incorporated announced that it is scheduled to report fourth quarter results on March 1, 2023 at 4:00 PM Eastern Time.

ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it will release financial results for its 2022 fourth quarter and full year on Wednesday, March 1, 2023, after the market close.